KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues

K Shibata, R Foglar, K Horie, K Obika, A Sakamoto, S Ogawa and G Tsujimoto

Department of Molecular and Cell Pharmacology, National Children's Medical Research Center, Tokyo, Japan.

alpha 1-Adrenoceptors (ARs) comprise a heterogeneous family, and subtype-selective ligands are valuable for studying the functional role of each receptor subtype. We characterized a newly synthesized, alpha 1- AR antagonist, KMD-3213, by using Chinese hamster ovary cells stably expressing the three cloned human alpha 1-ARs (alpha 1a, alpha 1b, and alpha 1d), as well as native rat and human tissues. KMD-3213 potently inhibited 2-[2-(4-hydroxy-3-[125I]iodophenyl)ethylaminomethyl]-alpha- tetralone binding to the cloned human alpha 1a-AR, with a Ki value of 0.036 nM, but had 583- and 56-fold lower potency at the alpha 1b- and alpha 1d-ARs, respectively. KMD-3213 inhibited norepinephrine-induced increases in intracellular Ca2+ concentrations in alpha 1a-AR- expressing Chinese hamster ovary cells with an IC50 of 0.32 nM but had a much weaker inhibitory effect on the alpha 1b- and alpha 1d-ARs. Using pharmacologically well characterized native rat tissues [submaxillary gland (alpha 1A-AR-expressing tissue), liver (alpha 1B-AR- expressing tissue), and heart (mixed alpha 1A- and alpha 1B-AR- expressing tissue)], binding studies showed that inhibition curves for KMD-3213 in submaxillary gland and liver best fit a one-site model (with Ki values of 0.15 and 16 nM, respectively), whereas KMD-3213 had high and low affinity sites in heart membranes. Chloroethylclonidine treatment of rat heart membranes completely eliminated the low affinity sites for KMD-3213. Furthermore, in human liver and prostate KMD-3213 could identify high and low affinity sites, the Ki values of which corresponded well to those for the cloned human alpha 1a- and alpha 1b- ARs, respectively. Moreover, the affinity of KMD-3213 was found to be approximately 10-fold higher at the cloned human alpha 1a-AR than at the cloned rat alpha 1a-AR. KMD-3213 is a potent and highly selective antagonist for the human alpha 1a-AR and would be useful for studying the physiological roles of human alpha 1-AR subtypes.

Volume 48, Issue 2, pp. 250-258, 08/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				C. Hosoda, T.-a. Koshimizu, A. Tanoue, Y. Nasa, R. Oikawa, T. Tomabechi, S. Fukuda, H. Shinoura, S. Oshikawa, S. Takeo, et al. Two {alpha}1-Adrenergic Receptor Subtypes Regulating the Vasopressor Response Have Differential Roles in Blood Pressure Regulation Mol. Pharmacol., March 1, 2005; 67(3): 912 - 922. [Abstract] [Full Text] [PDF]

				T.-a. Koshimizu, G. Tsujimoto, A. Hirasawa, Y. Kitagawa, and A. Tanoue Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human {alpha}1D- and {alpha}1B-adrenergic receptors Cardiovasc Res, September 1, 2004; 63(4): 662 - 672. [Abstract] [Full Text] [PDF]

				S. Oshikawa, A. Tanoue, T.-a. Koshimizu, Y. Kitagawa, and G. Tsujimoto Vasopressin Stimulates Insulin Release from Islet Cells through V1b Receptors: a Combined Pharmacological/Knockout Approach Mol. Pharmacol., March 1, 2004; 65(3): 623 - 629. [Abstract] [Full Text] [PDF]

				K. Shibata, S. Katsuma, T. Koshimizu, H. Shinoura, A. Hirasawa, A. Tanoue, and G. Tsujimoto alpha 1-Adrenergic Receptor Subtypes Differentially Control the Cell Cycle of Transfected CHO Cells through a cAMP-dependent Mechanism Involving p27Kip1 J. Biol. Chem., January 3, 2003; 278(1): 672 - 678. [Abstract] [Full Text] [PDF]

				J. E. Faber, N. Yang, and X. Xin Expression of alpha -Adrenoceptor Subtypes by Smooth Muscle Cells and Adventitial Fibroblasts in Rat Aorta and in Cell Culture J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 441 - 452. [Abstract] [Full Text] [PDF]

				S. Yamada, T. Okura, and R. Kimura In Vivo Demonstration of {alpha}1A-Adrenoceptor Subtype Selectivity of KMD-3213 in Rat Tissues J. Pharmacol. Exp. Ther., January 1, 2001; 296(1): 160 - 167. [Abstract] [Full Text]

				B. H. Wang, X.-J. Du, D. J. Autelitano, C. A. Milano, and E. A. Woodcock Adverse effects of constitutively active alpha 1B-adrenergic receptors after pressure overload in mouse hearts Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1079 - H1086. [Abstract] [Full Text] [PDF]

				V. L. Pulito, X. Li, S. S. Varga, L. S. Mulcahy, K. S. Clark, S. A. Halbert, A. B. Reitz, W. V. Murray, and L. K. Jolliffe An Investigation of the Uroselective Properties of Four Novel alpha 1a-Adrenergic Receptor Subtype-Selective Antagonists J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 224 - 229. [Abstract] [Full Text]

				K. Akiyama, M. Hora, S. Tatemichi, N. Masuda, S. Nakamura, R. Yamagishi, and M. Kitazawa KMD-3213, a Uroselective and Long-Acting alpha 1a-Adrenoceptor Antagonist, Tested in a Novel Rat Model J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 81 - 91. [Abstract] [Full Text]

				S. Yamada, T. Ohkura, Y. Deguchi, and R. Kimura In Vivo Measurement by [3H]Tamsulosin of alpha 1 Adrenoceptors in Rat Tissues in Relation to the Pharmacokinetics J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1575 - 1583. [Abstract] [Full Text]

				J.-M. Ye and E. Q. Colquhoun Changes in Functional Expression of Alpha-1 Adrenoceptors in Hindlimb Vascular Bed of Spontaneously Hypertensive Rats and their Effects on Oxygen Consumption J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 599 - 606. [Abstract] [Full Text]

				H. Yokoyama, M. Yasutake, and M. Avkiran {alpha}1-Adrenergic Stimulation of Sarcolemmal Na+-H+ Exchanger Activity in Rat Ventricular Myocytes : Evidence for Selective Mediation by the {alpha}1A-Adrenoceptor Subtype Circ. Res., June 1, 1998; 82(10): 1078 - 1085. [Abstract] [Full Text] [PDF]

				K. Shibata, A. Hirasawa, R. Foglar, S. Ogawa, and G. Tsujimoto Effects of Quinidine and Verapamil on Human Cardiovascular {alpha}1-Adrenoceptors Circulation, April 7, 1998; 97(13): 1227 - 1230. [Abstract] [Full Text] [PDF]

				A. Hirasawa, T. Sugawara, T. Awaji, K. Tsumaya, H. Ito, and G. Tsujimoto Subtype-Specific Differences in Subcellular Localization of alpha 1-Adrenoceptors: Chlorethylclonidine Preferentially Alkylates the Accessible Cell Surface alpha 1-Adrenoceptors Irrespective of the Subtype Mol. Pharmacol., November 1, 1997; 52(5): 764 - 770. [Abstract] [Full Text]

				A. Leonardi, J. P. Hieble, L. Guarneri, D. P. Naselsky, E. Poggesi, G. Sironi, A. C. Sulpizio, and R. Testa J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1272 - 1283. [Abstract] [Full Text]

				K. Kishi, H. Hayashi, L. Wang, S. Kamohara, K. Tamaoka, T. Shimizu, F. Ushikubi, S. Narumiya, and Y. Ebina Gq-coupled Receptors Transmit the Signal for GLUT4 Translocation via an Insulin-independent Pathway J. Biol. Chem., October 25, 1996; 271(43): 26561 - 26568. [Abstract] [Full Text] [PDF]

				R. M. Graham, D. M. Perez, J. Hwa, and M. T. Piascik {alpha}1-Adrenergic Receptor Subtypes : Molecular Structure, Function, and Signaling Circ. Res., May 1, 1996; 78(5): 737 - 749. [Full Text]